Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.

KEYTRUDA is a prescription medicine used to treat: a kind of lung cancer called non–small cell lung cancer (NSCLC). It may be used in combination with chemotherapy that contains platinum and …

Oct 13, 2025 · Learn about cost, uses, and more of Keytruda (pembrolizumab). It's a prescription drug that treats certain cancers in adults and some children.

Feb 11, 2026 · Find patient medical information for Keytruda (Pembrolizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Pembrolizumab, sold under the brand name Keytruda, is a humanized monoclonal antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy to treat many types of cancer. [12][14] It …

Feb 11, 2026 · Thirteen years after the FDA first blessed Merck's Keytruda for melanoma, it has approved the PD-1 superstar for a certain type of ovarian cancer.

Oct 20, 2025 · KEYTRUDA® (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)

Jul 28, 2021 · Keytruda is a PD-1 checkpoint inhibitor approved for inoperable or metastatic melanoma, adjuvant treatment of melanoma after surgery, non-small-cell lung cancer, bladder (urothelial) …

Oct 29, 2025 · Keytruda (chemical name: pembrolizumab) is an immunotherapy used to treat some types of triple-negative, MSI-H, dMMR, and TMB-H breast cancer.

KEYTRUDA and KEYTRUDA QLEX are each indicated for the treatment of adult patients with resectable (tumors ≥4 cm or node positive) non–small cell lung cancer (NSCLC) in combination with …